Namit, Eliezer M.

HRN: 27-56-84  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2025
CLARITHROMYCIN 500MG (CAP)
08/03/2025
08/17/2025
PO
500mg
BID
H. Pylori Infection
Remove - Pending Acceptance
08/03/2025
METRONIDAZOLE 500MG (TAB)
08/03/2025
08/17/2025
PO
500mg
BID
H. Pylori Infection
Remove - Pending Acceptance
08/15/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/15/2025
09/05/2025
IV
2.25g
Q6h
Acute Bacterial Infection, Resistance
Checking Initial Appropriateness 
08/26/2025
MUPIROCIN 2%, 15G (TUBE)
08/26/2025
09/01/2025
TOPICAL
Apply Bid
BID
Decubitus Ulcer
Checking Initial Appropriateness 
09/04/2025
MUPIROCIN 2%, 15G (TUBE)
09/04/2025
09/11/2025
TOPICAL
2%
BID
Sacral Ulcer
Checking Initial Appropriateness 
09/04/2025
MUPIROCIN 2%, 15G (TUBE)
09/04/2025
09/11/2025
TOPICAL
2%
BID
Sacral Ulcer
Checking Initial Appropriateness 
09/11/2025
MUPIROCIN 2%, 15G (TUBE)
09/11/2025
09/17/2025
TOPICAL
15g
BID
Sacral Ulcer
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: